Receptos to Present at Bank of America Merrill Lynch 2015 Healthcare Conference
07 Maggio 2015 - 2:00PM
Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company
developing therapeutic candidates for the treatment of immune and
metabolic diseases, today announced that Faheem Hasnain, its
President and Chief Executive Officer, will be presenting at the
Bank of America Merrill Lynch 2015 Healthcare Conference at the
Encore Hotel in Las Vegas, NV. The presentation is scheduled
for Wednesday, May 13th at 3:00pm Pacific time.
About Receptos
Receptos is a biopharmaceutical company developing
therapeutic candidates for the treatment of immune and metabolic
diseases. The Company's lead program, RPC1063, is a sphingosine
1-phosphate 1 and 5 receptor small molecule modulator in
development for immune indications including relapsing multiple
sclerosis and inflammatory bowel disease. Patents supporting
RPC1063 were exclusively licensed to Receptos from The
Scripps Research Institute (TSRI). The Company is also
developing RPC4046, an anti-interleukin-13 (IL-13) antibody for
eosinophilic esophagitis (EoE), an allergic/immune-mediated orphan
disease.
CONTACT: Media and Investor Contact:
Graham K. Cooper
Chief Financial Officer, Receptos
(858) 652-5708
gcooper@receptos.com
Grafico Azioni RECEPTOS, INC. (NASDAQ:RCPT)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni RECEPTOS, INC. (NASDAQ:RCPT)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a (MM) (NASDAQ): 0 articoli recenti
Più Articoli Notizie